Literature DB >> 18202407

Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease.

Lisa A Kachnic, Theodore S Hong, David P Ryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18202407     DOI： 10.1200/JCO.2007.14.6365

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard?

Authors:  Claudio Fucini; Filippo Pucciani; Claudio Elbetti; Riccardo Gattai; Antonio Russo
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 3.  The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation.

Authors:  Arthur Affleck Iv; Marina Affi Koprowski; Nima Nabavizadeh; Vassiliki Liana Tsikitis
Journal:  Ann Gastroenterol       Date:  2022-04-07

4.  Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy.

Authors:  Jason Wei-Min Lim; Min-Hoe Chew; Kiat-Hon Lim; Choong-Leong Tang
Journal:  Int J Colorectal Dis       Date:  2012-08-24       Impact factor: 2.571

5.  Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.

Authors:  Ji Zhu; Ye Xu; Weilie Gu; Junjie Peng; Gang Cai; Guoxiang Cai; Wenjie Sun; Weiqi Shen; Sanjun Cai; Zhen Zhang
Journal:  Radiat Oncol       Date:  2010-12-15       Impact factor: 3.481

6.  Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.

Authors:  Robert Siegel; Susen Burock; Klaus-Dieter Wernecke; Albrecht Kretzschmar; Manfred Dietel; Volker Loy; Stephan Koswig; Volker Budach; Peter M Schlag
Journal:  BMC Cancer       Date:  2009-02-06       Impact factor: 4.430

7.  Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer.

Authors:  Jun Li; Yue Liu; Jian-Wei Wang; Yang Gao; Ye-Ting Hu; Jin-Jie He; Xiu-Yan Yu; Han-Guang Hu; Ying Yuan; Su-Zhan Zhang; Ke-Feng Ding
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

8.  Total mesorectal excision for the treatment of rectal cancer.

Authors:  Ali Zedan; Tareq Salah
Journal:  Electron Physician       Date:  2015-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.